The emerging role of cannabinoid neuromodulators in symptom management

被引：31

作者：

Davis, Mellar

Maida, Vincent

Daeninck, Paul

Pergolizzi, Joseph

机构：

[1] Cleveland Clin, Harry R Horvitz Ctr Palliat Med, Cleveland, OH 44195 USA

[2] William Osler Hlth Ctr, Toronto, ON, Canada

[3] Univ Toronto, Toronto, ON, Canada

[4] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada

[5] Univ Manitoba, Dept Family Med, Winnipeg, MB, Canada

[6] CancerCare Manitoba, Winnipeg, MB, Canada

[7] Winnipeg Reg Palliat Care Program, Winnipeg, MB, Canada

[8] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[9] Natl Inst Pain, COPE, New York, NY USA

[10] Naples Anesthesia & Pain Associates, Naples, FL USA

来源：

SUPPORTIVE CARE IN CANCER | 2007年 / 15卷 / 01期

关键词：

cannabinoids; chemotherapy-induced nausea and vomiting; CB1 and CB2 receptors; pain;

D O I：

10.1007/s00520-006-0180-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Introduction: The cannabinoids nabilone (Cesamet) and dronabinol (Marinol) are indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in cancer patients who have failed to respond adequately to conventional antiemetic therapy. Discussion: The endocannabinoid (CB) system interacts with numerous other systems and pharmaceutical cannabinoids target ubiquitous CB1 and CB2 receptors in the central nervous system and periphery, relieving nausea and vomiting and pain. Summary: The benefits of this novel class of medications in cancer may extend beyond CINV, as indicated by data from preclinical studies and animal models.

引用

页码：63 / 71

页数：9

共 50 条

[1] The emerging role of cannabinoid neuromodulators in symptom management
Mellar Davis
Vincent Maida
Paul Daeninck
Joseph Pergolizzi
Supportive Care in Cancer, 2007, 15 : 63 - 71
[2] Emerging properties of cannabinoid medicines in management of multiple sclerosis
Pryce, G
Baker, D
TRENDS IN NEUROSCIENCES, 2005, 28 (05) : 272 - 276
[3] The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients
Maida, V.
BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (01) : 121 - 122
[4] The role of neuromodulators in selective attention
Noudoost, Behrad
Moore, Tirin
TRENDS IN COGNITIVE SCIENCES, 2011, 15 (12) : 585 - 591
[5] Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Bo, Yiming
Zhao, Xin
Li, Liliang
CLINICAL SCIENCE, 2024, 138 (06) : 413 - 434
[6] Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management
Shah, Siddharth A.
Gupta, Anand Shyamlal
Kumar, Piyush
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (01) : 1 - 9
[7] Pathogenesis of Migraine: Role of Neuromodulators
D'Andrea, Giovanni
D'Arrigo, Antonello
Dalle Carbonare, Maurizio
Leon, Alberta
HEADACHE, 2012, 52 (07): : 1155 - 1163
[8] Role of Neuromodulators for the Management of Post-Gastric-Fundoplication Dyspepsia: A Retrospective Series
Singh, Achintya
Ford, Andrew M.
McMichael, John
Gabbard, Scott
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
[9] Is there a role for medicinal cannabis in symptom management?
Hardy, Janet
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 74 - 75
[10] Neuromodulators for pain management in rheumatoid arthritis
Richards, Bethan L.
Whittle, Samuel L.
Buchbinder, Rachelle
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):

← 1 2 3 4 5 →